Loading...

Home
ETF
ROIV

ROIV

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ROIV News

Roivant Sciences Q4 2025 Earnings Call Insights Highlight Key Developments

May 20 2026seekingalpha

Roivant (ROIV) Q4 2025 Earnings Transcript

May 20 2026NASDAQ.COM

Roivant Sciences Releases Preliminary Data from 1402 Study

May 20 2026Yahoo Finance

Roivant Sciences Reports $355.7M Net Income, Shares Surge

May 20 2026stocktwits

Immunovant's Phase 2 Trial Results Show Promising Efficacy for IMVT-1402

May 20 2026seekingalpha

Roivant Sciences Q4 Earnings Beat Expectations

May 20 2026seekingalpha

Roivant Sciences to Announce Q4 Earnings on May 20

May 19 2026seekingalpha

Moderna Surpasses Q1 Revenue Estimates Driven by International Vaccine Sales

May 01 2026Newsfilter

Roivant Sciences (ROIV.US) Officer Plans to Sell $8.45 Million in Common Stock via Form 144 Amendment

Apr 16 2026moomoo

Priovant Launches Phase 2b/3 Trial for Lichen Planopilaris

Apr 02 2026Newsfilter

Roivant Launches New Clinical Trial for LPP

Apr 02 2026Newsfilter

S&P 500 Futures Rise in Pre-Market Session; United Therapeutics and Alcoa Take the Lead

Mar 30 2026Barron's

Brepocitinib Shows Significant Benefits in Dermatomyositis Trial

Mar 28 2026Newsfilter

ROIV Options Contract Analysis and Investment Opportunities

Mar 06 2026NASDAQ.COM

BlackBarn Capital Increases Warby Parker Stake by 2 Million Shares

Mar 05 2026NASDAQ.COM

BlackBarn Capital Increases Warby Parker Stake to 3 Million Shares

Mar 05 2026Fool